Dr. Esther Black
Dr. Penni Black is an Associate Professor of Pharmaceutical Sciences and Director of the Professional Program. She received her undergraduate degree from Clemson University and PhD from the University of Florida. Dr. Black completed postdoctoral training in cancer biology and computational biology at Duke University. Her research interests lie understanding the signaling pathways responsible for resistance to targeted therapeutics in lung cancer in order to improve personalization of cancer therapies. Our lab also utilizes patient outcomes data to anticipate response to therapies that target the immune response in lung cancer. Dr. Black teaches in both the professional and graduate curriculum, providing content in cell biology /signaling and oncology.